Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Short term Debt: 2011-2022

Historic Short term Debt for Capricor Therapeutics (CAPR) over the last 5 years, with Dec 2022 value amounting to $89,234.

  • Capricor Therapeutics' Short term Debt fell 80.21% to $18,628 in Q2 2023 from the same period last year, while for Jun 2023 it was $18,628, marking a year-over-year decrease of 80.21%. This contributed to the annual value of $89,234 for FY2022, which is 85.11% down from last year.
  • Capricor Therapeutics' Short term Debt amounted to $89,234 in FY2022, which was down 85.11% from $599,388 recorded in FY2021.
  • In the past 5 years, Capricor Therapeutics' Short term Debt ranged from a high of $599,388 in FY2021 and a low of $89,234 during FY2022.
  • Moreover, its 2-year median value for Short term Debt was $344,311 (2021), whereas its average is $344,311.
  • Data for Capricor Therapeutics' Short term Debt shows a maximum YoY plummeted of 85.11% (in 2022) over the last 5 years.
  • Over the past 2 years, Capricor Therapeutics' Short term Debt (Yearly) stood at $599,388 in 2021, then crashed by 85.11% to $89,234 in 2022.